Optimapharm Lithuania UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 743,587 |
| 50,208 |
| 28,459 |
| 23,508 |
| 1,587 |
| 13.48 |
| 3.16 |
| 228,246 |
| 101,685 |
| 0 |
| 329,722 |
| 0.31 |
| 0.45 |
| - |
| - |
| 3.95 |
| 29,396 |
| 2023 |
|---|
| 1,020,985 |
| 69,172 |
| 56,423 |
| 36,814 |
| 2,494 |
| 15.25 |
| 3.61 |
| 265,060 |
| 264,334 |
| 706 |
| 507,249 |
| 0.24 |
| 1.00 |
| - |
| - |
| 5.53 |
| 56,429 |
| 2024 |
|---|
| 952,307 |
| 66,502 |
| 60,287 |
| 50,440 |
| 3,522 |
| 16.16 |
| 5.30 |
| 315,500 |
| 263,016 |
| 706 |
| 364,790 |
| 0.11 |
| 0.83 |
| - |
| - |
| 6.33 |
| 60,287 |
| 2024 |
|---|
| 952,307 |
| 66,502 |
| 60,287 |
| 50,440 |
| 3,522 |
| 16.16 |
| 5.30 |
| 315,500 |
| 263,016 |
| 706 |
| 364,790 |
| 0.11 |
| 0.83 |
| - |
| - |
| 6.33 |
| 60,287 |
Turnover (€)
2024
Turnover (€)
952,307 €-7 % *
Sales per employee (€)
66,502 €-4 % *
Profit before tax (€)
60,287 €7 % *
Net Profit (€)
50,440 €37 % *
Profit per employee (€)
3,522 €41 % *
Total profitability (%)
16.16 %5.97 % *
Net profitability (%)
5.30 %46.81 % *
Equity (€)
315,500 €19 % *
Amounts Payable And Liabilities (€)
263,016 €-1 % *
Non-current Assets (€)
706 €0 % *
CurrentAssets (€)
364,790 €-28 % *
Working capital requirement
0.11 -54.17 % *
Debt-to-equity ratio
0.83 -17.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
6.33 %14.47 % *
EBIT (€)
60,287 €7 % *
